Ritter Pharmaceuticals, Inc.

( )
RTTR After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
VRXValeant Pharmaceuticals International, Inc. 0.36%26.5114.1%$155.99m
AMRNAmarin Corp. Plc 0.34%17.931.7%$95.63m
CTLTCatalent, Inc. 0.34%59.002.2%$76.29m
RVMDRevolution Medicines, Inc. -1.87%30.420.0%$61.13m
JAZZJazz Pharmaceuticals Plc -0.50%134.822.3%$58.92m
GWPHGW Pharmaceuticals Plc -2.23%125.696.2%$56.24m
AXSMAxsome Therapeutics, Inc. -1.58%91.131.9%$53.92m
UTHRUnited Therapeutics Corp. -0.43%106.9614.3%$49.22m
ZGNXZogenix, Inc. -2.46%30.169.4%$43.27m
HZNPHorizon Therapeutics Plc -1.50%35.506.6%$43.25m
PRGOPerrigo Co. Plc 0.52%59.926.8%$42.27m
SAGESAGE Therapeutics, Inc. -1.21%69.538.6%$42.00m
ICPTIntercept Pharmaceuticals, Inc. 1.15%94.9916.9%$40.20m
MNKMallinckrodt Plc -0.68%5.1320.9%$33.92m
ENDPEndo International Plc -0.66%6.078.8%$33.92m

Company Profile

Ritter Pharmaceuticals, Inc. engages in the development of novel therapeutic products which modulate the human gut microbiome to treat digestive disorders and gastrointestinal diseases. It focuses on the development and commercialization of RP-G28. The company was founded by Andrew J. Ritter and Ira E. Ritter on March 29, 2004 and is headquartered in Los Angeles, CA.